Company Profile | May 11, 2000

AAI Corporate Headquarters

Source: AAIPharma Inc.
Providing product development and support services to the worldwide pharmaceutical and biotechnology industries.

AAI's integrated services help clients rapidly progress with all aspects of product development, from pre-clinical dosage development to Phase I, II, III and IV clinical trial capabilities. AAI's state-of-the-art facilities located in the United States, Europe and the Pacific Rim, renowned expertise, and broad scientific capabilities provide clients with seamless service that ultimately increases speed-to-market.

The company has completed projects for 47 of the world's top 50 drug companies and has experience with over 1,500 products. AAI's broad range of integrated, value-added services span the drug life cycle, from new compound characterization and synthesis to marketed-product compliance and quality control testing. In addition, through its Internal Development Program, AAI leverages its expertise to generate revenue by licensing internally developed drugs to third parties.

AAI is a publicly traded company whose shares are traded on NASDAQ under the ticker symbol AAII.

Services Offered:

  • Analytical Development
  • Quality Control Testing
  • Stability Studies
  • Microbiology
  • Physical Chemistry
  • Validation Support Services
  • Biotechnology
  • Formulation Development
  • Regulatory Affairs
  • Clinical Trials Manufacturing
  • Clinical Distribution
  • Phase I-IV Clinical Trials
  • Central Clinical Laboratory
  • Bioanalytical Testing
  • Biostatistical Analysis
  • Data Management
  • Seminars & Training
  • QA/QC Consulting